377
Views
12
CrossRef citations to date
0
Altmetric
Review Article

Liver toxicity mechanisms of herbs commonly used in Latin America

, , , &
Pages 338-356 | Received 05 Apr 2017, Accepted 24 May 2017, Published online: 04 Jul 2017

References

  • Akdogan, M., et al., 2004. Investigation of biochemical and histopathological effects of Mentha piperita Labiatae and Mentha spicata Labiatae on liver tissue in rats. Human & experimental toxicology, 23, 21–28.
  • Alkerwi, A., et al., 2015. Tea, but not coffee consumption, is associated with components of arterial pressure. The observation of cardiovascular risk factors study in Luxembourg. Nutrition research (New York, NY), 35, 557–565.
  • Al-Ramahi, R., et al., 2015. Evaluation of potential drug–herb interactions among a group of Palestinian patients with chronic diseases. BMC complementary and alternative medicine, 15, 221.
  • Alves, J.G., De Brito Rde, C., and Cavalcanti, T.S., 2012. Effectiveness of Mentha piperita in the treatment of infantile colic: a crossover study. Evidence-based complementary and alternative medicine, 2012, 981352.
  • Andrade-Cetto, A. and Heinrich, M., 2005. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. Journal of ethnopharmacology, 99, 325–348.
  • Anesini, C., Ferraro, G.E., and Filip, R., 2008. Total polyphenol content and antioxidant capacity of commercially available tea (Camellia sinensis) in Argentina. Journal of agricultural and food chemistry, 56, 9225–9229.
  • Anon., 2002–2005. World Health Organization. WHO traditional medicine strategy. Geneva: World Health Organization.
  • Anon., 2013. World Health Organization. WHO traditional medicine strategy 2014–2023. Geneva: World Health Organization.
  • Anon., 2016. Messages from the Gods: a guide to the useful plants of Belize by Michael J. Balick and Rosita Arvigo. The quarterly review of biology, 91, 374–374.
  • Anzoise, M.L., et al., 2016. Beneficial properties of Passiflora caerulea on experimental colitis. Journal of ethnopharmacology, 194, 137–145.
  • Arbo, M.D., et al., 2008. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine. Food and chemical toxicology, 46, 2770–2775.
  • Arteaga, S., Andrade-Cetto, A., and Cardenas, R., 2005. Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid. Journal of ethnopharmacology, 98, 231–239.
  • Avila, H., et al., 1997. Cytotoxicity of a low molecular weight fraction from Aloe vera (Aloe barbadensis Miller) gel. Toxicon, 35, 1423–1430.
  • Bai, W., et al., 2007. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas, 58, 31–41.
  • Bajaj, S., et al., 1999. Immunomodulatory activity of a Unani gold preparation used in Indian system of medicine. Immunopharmacology and immunotoxicology, 21, 151–161.
  • Balderas, J.L., et al., 2008. Pharmacodynamic interaction of the sedative effects of Ternstroemia pringlei (Rose) Standl. with six central nervous system depressant drugs in mice. Journal of ethnopharmacology, 119, 47–52.
  • Balderas-Lopez, J.L., et al., 2013. Toxic rather than neuropharmacological effect of Ternstroemia sylvatica fruits and identification of 28-O-[beta-l-6-rhamnopyranosyl]-R1-barrigenol as a new compound with toxic effects in mice. Pharmaceutical biology, 51, 1451–1458.
  • Barnes, L., Anderson, L.A., and Phillipson, J.D., 2007. Herbal medicines. 3rd ed. London: Pharmaceutical Press.
  • Batchelor, W.B., Heathcote, J., and Wanless, I.R., 1995. Chaparral-induced hepatic injury. The American journal of gastroenterology, 90, 831–833.
  • Ben Yahia, M., et al., 1993. Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases. Gastroentérologie clinique et biologique, 17, 959–962.
  • Benninger, J., et al., 1999. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Gastroenterology, 117, 1234–1237.
  • Bertea, C.M., et al., 2001. Demonstration that menthofuran synthase of mint (Mentha) is a cytochrome P450 monooxygenase: cloning, functional expression, and characterization of the responsible gene. Archives of biochemistry and biophysics, 390, 279–286.
  • Bessone, F., et al., 2016. The Latin American DILI registry experience: a successful ongoing collaborative strategic initiative. International journal of molecular sciences, 17, 313.
  • Bjornsson, E.S., et al., 2013. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology, 144, 1419–1425. 1425e1–1425e3; quiz e19–e20.
  • Boby, R.G. and Indira, M., 2003. The impact of cyanoglycoside rich fraction isolated from Cassava (Manihot esculenta) on alcohol induced oxidative stress. Toxicon, 42, 367–372.
  • Bogacz, A., et al., 2014. The influence of standardized Valeriana officinalis extract on the CYP3A1 gene expression by nuclear receptors in in vivo model. BioMed research international, 2014, 819093.
  • Borrelli, F. and Ernst, E., 2008. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. American journal of obstetrics and gynecology, 199, 455–466.
  • Bottenberg, M.M., et al., 2007. Oral aloe vera-induced hepatitis. The annals of pharmacotherapy, 41, 1740–1743.
  • Bressler, R., 2005. Herb–drug interactions: interactions between kava and prescription medications. Geriatrics, 60, 24–25.
  • Bunchorntavakul, C. and Reddy, K.R., 2013. Review article: herbal and dietary supplement hepatotoxicity. Alimentary pharmacology & therapeutics, 37, 3–17.
  • Bussmann, R.W. and Glenn, A., 2010. Medicinal plants used in Northern Peru for reproductive problems and female health. Journal of ethnobiology and ethnomedicine, 6, 30.
  • Calapai, G., et al., 2016. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products – Part 3: Mentha × piperita – Solanum dulcamara. Contact dermatitis, 74, 131–144.
  • Calitz, C., et al., 2015. Herbal hepatotoxicity: current status, examples, and challenges. Expert opinion on drug metabolism & toxicology, 11, 1551–1565.
  • Camargo, L.E., et al., 2016. Antioxidant and antifungal activities of Camellia sinensis (L.) Kuntze leaves obtained by different forms of production. Brazilian journal of biology, 76, 428–434.
  • Campos, L.B., et al., 2012. Cimicifuga racemosa impairs fatty acid beta-oxidation and induces oxidative stress in livers of ovariectomized rats with renovascular hypertension. Free radical biology & medicine, 53, 680–689.
  • Cappello, G., et al., 2007. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Digestive and liver disease, 39, 530–536.
  • Carraz, M., et al., 2015. Antiproliferative activity and phenotypic modification induced by selected Peruvian medicinal plants on human hepatocellular carcinoma Hep3B cells. Journal of ethnopharmacology, 166, 185–199.
  • Centers for Disease and Prevention, 2004. Lead poisoning associated with Ayurvedic medications – five states, 2000–2003. Morbidity and mortality weekly report (MMWR), 53, 582–584.
  • Chalasani, N., et al., 2008. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology, 135, 1924–1934. 1934e1–1934e4.
  • Chalasani, N., et al., 2015. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study. Gastroenterology, 148, 1340–1352e7.
  • Chander, M.P., Kartick, C., and Vijayachari, P., 2015. Medicinal plants used by the Nicobarese inhabiting little Nicobar Island of the Andaman and Nicobar Archipelago, India. Journal of alternative and complementary medicine, 21, 373–379.
  • Chau, C.F. and Huang, Y.L., 2005. Effects of the insoluble fiber derived from Passiflora edulis seed on plasma and hepatic lipids and fecal output. Molecular nutrition & food research, 49, 786–790.
  • Chung, J.H., et al., 1996. Acceleration of the alcohol oxidation rate in rats with aloin, a quinone derivative of Aloe. Biochemical pharmacology, 52, 1461–1468.
  • Cohen, D.L. and Del Toro, Y., 2008. A case of valerian-associated hepatotoxicity. Journal of clinical gastroenterology, 42, 961–962.
  • Colombo, M.L. and Bosisio, E., 1996. Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacological research, 33, 127–134.
  • Cravotto, G., et al., 2010. Phytotherapeutics: an evaluation of the potential of 1000 plants. Journal of clinical pharmacy and therapeutics, 35, 11–48.
  • Cruz Bárcenas, A., 2007. Boom en el consumo de té en México; crece 20% anual La Jornada.
  • Cui, Z., et al., 2015. p-Synephrine suppresses glucose production but not lipid accumulation in H4IIE liver cells. Journal of medicinal food, 18, 76–82.
  • Curciarello, J., et al., 2008. Severe acute hepatitis associated with intake of Aloe vera tea. Gastroenterologia y hepatologia, 31, 436–438.
  • Da Silva, J., et al., 2002. Evaluation of the genotoxic effect of rutin and quercetin by comet assay and micronucleus test. Food and chemical toxicology, 40, 941–947.
  • Da Silva-Pereira, J.F., et al., 2016. Fast hepatic biotransformation of p-synephrine and p-octopamine and implications for their oral intake. Food & function, 7, 1483–1491.
  • Dalla Corte, C.L., et al., 2008. Potentially adverse interactions between haloperidol and valerian. Food and chemical toxicology, 46, 2369–2375.
  • Danan, G. and Teschke, R., 2015. RUCAM in drug and herb induced liver injury: the update. International journal of molecular sciences, 17 (1), pii: E14.
  • Davies, L.P., et al., 1992. Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. Pharmacology & toxicology, 71, 120–126.
  • De Araujo, M.F.M., et al., 2017. The effect of flour from the rind of the yellow passion fruit on glycemic control of people with diabetes mellitus type 2: a randomized clinical trial. Journal of diabetes & metabolic disorders, 16, 18.
  • De Berardinis, V., et al., 2000. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Molecular pharmacology, 58, 542–551.
  • De Bruiji, G., 1971. Study ducarectere cyanogentique du Manioc (Manihot esculenta). Mededelingen landbouwhogeschool, 13, 140.
  • De Oliveira, A.L., et al., 2014. The action of p-synephrine on hepatic carbohydrate metabolism and respiration occurs via both Ca(2+)-mobilization and cAMP production. Molecular and cellular biochemistry, 388, 135–147.
  • Del Vecchyo-Tenorio, G., et al., 2016. Creosote Bush (Larrea tridentata) improves insulin sensitivity and reduces plasma and hepatic lipids in hamsters fed a high fat and cholesterol diet. Frontiers in pharmacology, 7, 194.
  • Deleve, L.D., et al., 2003. Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. American journal of physiology – gastrointestinal and liver physiology, 284, G1045–G1052.
  • Dhawan, K., Dhawan, S., and Sharma, A., 2004. Passiflora: a review update. Journal of ethnopharmacology, 94, 1–23.
  • Dresser, G.K., et al., 2002. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. Clinical pharmacology and therapeutics, 72, 247–255.
  • Elbling, L., et al., 2005. Green tea extract and (–)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. The FASEB journal, 19, 807–809.
  • Ernst, E., 2002. Heavy metals in traditional Indian remedies. European journal of clinical pharmacology, 57, 891–896.
  • Ernst, E. and Hung, S.K., 2011. Great expectations: what do patients using complementary and alternative medicine hope for? Patient, 4, 89–101.
  • Espinoza, E.O., Mann, M.J., and Bleasdell, B., 1995. Arsenic and mercury in traditional Chinese herbal balls. The New England journal of medicine, 333, 803–804.
  • Fau, D., et al., 1997. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology, 113, 1334–1346.
  • Feliu-Hemmelmann, K., Monsalve, F., and Rivera, C., 2013. Melissa officinalis and Passiflora caerulea infusion as physiological stress decreaser. International journal of clinical and experimental medicine, 6, 444–451.
  • Fischer, F.C., Fung, S.Y., and Lankhorst, P.P., 1982. Cyanogenesis in Passifloraceae. Planta medica, 45, 42–45.
  • Fisher, A.A., Purcell, P., and Le Couteur, D.G., 2000. Toxicity of Passiflora incarnata L. Journal of toxicology. Clinical toxicology, 38, 63–66.
  • Frenzel, C. and Teschke, R., 2016. Herbal hepatotoxicity: clinical characteristics and listing compilation. International journal of molecular sciences, 17 (5), pii: E588.
  • Frye, A. and Haustein, C., 2007. Extraction, identification, and quantification of harmala alkaloids in three species of Passiflora. American journal of undergraduate research, 6, 19–26.
  • Fu, P.P., et al., 2004. Pyrrolizidine alkaloids–genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug metabolism reviews, 36, 1–55.
  • Fu, P.P., et al., 2008. Toxicity of kava kava. Journal of environmental science and health. Part C, environmental carcinogenesis & ecotoxicology reviews, 26, 89–112.
  • Fujiwara, T., et al., 1998b. Nordihydroguaiaretic acid blocks protein transport in the secretory pathway causing redistribution of Golgi proteins into the endoplasmic reticulum. The journal of biological chemistry, 273, 3068–3075.
  • Fujiwara, T., Misumi, Y., and Ikehara, Y., 1998a. Dynamic recycling of ERGIC53 between the endoplasmic reticulum and the Golgi complex is disrupted by nordihydroguaiaretic acid. Biochemical and biophysical research communications, 253, 869–876.
  • Garcia-Ruiz, A., et al., 2017. Banana passion fruit (Passiflora mollissima (Kunth) L.H. Bailey): microencapsulation, phytochemical composition and antioxidant capacity. Molecules, 22 (1), pii: E85.
  • Giavina-Bianchi, P.F., Jr., et al., 1997. Occupational respiratory allergic disease induced by Passiflora alata and Rhamnus purshiana. Annals of allergy, asthma & immunology, 79, 449–454.
  • Gilca, M., et al., 2010. Chelidonium majus – an integrative review: traditional knowledge versus modern findings. Forschende komplementärmedizin/Research in complementary medicine, 17, 241–248.
  • Gonzalez Ayala, J.C., 1994. Botanica medicinal popular. Etnobotanica Medicinal de El Salvador. San Salvador: Jardin Botanico La Laguna.
  • Grünwald, J. and Jänicke, C., 2014. La farmacia verde. 2nd ed. España: Everest.
  • Gursoy, N. and Tepe, B., 2009. Determination of the antimicrobial and antioxidative properties and total phenolics of two “endemic” Lamiaceae species from Turkey: Ballota rotundifolia L. and Teucrium chamaedrys C. Koch. Plant foods for human nutrition, 64, 135–140.
  • Hadley, S. and Petry, J.J., 2003. Valerian. American family physician, 67, 1755–1758.
  • Hellum, B.H., Hu, Z., and Nilsen, O.G., 2009. Trade herbal products and induction of CYP2C19 and CYP2E1 in cultured human hepatocytes. Basic & clinical pharmacology & toxicology, 105, 58–63.
  • Henneicke-Von Zepelin, H.H., 2017. 60 years of Cimicifuga racemosa medicinal products: clinical research milestones, current study findings and current development. Wiener medizinische wochenschrift, 167, 147–159.
  • Hilgert, N.I., 2001. Plants used in home medicine in the Zenta River basin, Northwest Argentina. Journal of ethnopharmacology, 76, 11–34.
  • Houghton, P.J., 1988. The biological activity of Valerian and related plants. Journal of ethnopharmacology, 22, 121–142.
  • Houghton, P.J., 1999. The scientific basis for the reputed activity of Valerian. The journal of pharmacy and pharmacology, 51, 505–512.
  • Ifeoma, O. and Oluwakanyinsola, S., 2013. Screening of herbal medicines for potential toxicities. Idu, Abuja, Nigeria: INTECH Open Access Publisher.
  • Imai, K., Suga, K., and Nakachi, K., 1997. Cancer-preventive effects of drinking green tea among a Japanese population. Preventive medicine, 26, 769–775.
  • Ingawale, D.K., Mandlik, S.K., and Naik, S.R., 2014. Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): a critical discussion. Environmental toxicology and pharmacology, 37, 118–133.
  • Inoue, H., et al., 2011. High-dose green tea polyphenols induce nephrotoxicity in dextran sulfate sodium-induced colitis mice by down-regulation of antioxidant enzymes and heat-shock protein expressions. Cell stress chaperones, 16, 653–662.
  • Jatoi, A., et al., 2003. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer, 97, 1442–1446.
  • Jhoo, J.W., et al., 2006. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum). Journal of agricultural and food chemistry, 54, 3157–3162.
  • Johnson, J.D., Conroy, W.G., and Isom, G.E., 1987b. Alteration of cytosolic calcium levels in PC12 cells by potassium cyanide. Toxicology and applied pharmacology, 88, 217–224.
  • Johnson, J.D., et al., 1987a. Peroxidation of brain lipids following cyanide intoxication in mice. Toxicology, 46, 21–28.
  • Johnson, J.D., Meisenheimer, T.L., and Isom, G.E., 1986. Cyanide-induced neurotoxicity: role of neuronal calcium. Toxicology and applied pharmacology, 84, 464–469.
  • Jussofie, A., Schmiz, A., and Hiemke, C., 1994. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology (Berl), 116, 469–474.
  • Kakehashi, A., et al., 2014. Valerian inhibits rat hepatocarcinogenesis by activating GABA(A) receptor-mediated signaling. PLoS One, 9, e113610.
  • Kanat, O., Ozet, A., and Ataergin, S., 2006. Aloe vera-induced acute toxic hepatitis in a healthy young man. European journal of internal medicine, 17, 589.
  • Katz, M. and Saibil, F., 1990. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. Journal of clinical gastroenterology, 12, 203–206.
  • Kean, R.J., et al., 2015. Chronic consumption of flavanone-rich orange juice is associated with cognitive benefits: an 8-wk, randomized, double-blind, placebo-controlled trial in healthy older adults. The American journal of clinical nutrition, 101, 506–514.
  • Kim, M., et al., 2005. (–)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Carcinogenesis, 26, 1553–1562.
  • Konta, E.M., et al., 2014. Evaluation of the antihypertensive properties of yellow passion fruit pulp (Passiflora edulis Sims f. flavicarpa Deg.) in spontaneously hypertensive rats. Phytotherapy research, 28, 28–32.
  • Korth, C., 2014. Drug-induced hepatotoxicity of select herbal therapies. Journal of pharmacy practice, 27, 567–572.
  • Krosnick, S.E., Xun-Lin, Y., and Deng, Y., 2013. The rediscovery of Passiflora kwangtungensis Merr. (subgenus Decaloba supersection Disemma): a critically endangered Chinese endemic. PhytoKeys, 23, 55–74.
  • Kujawska, M. and Pieroni, A., 2015. Plants used as food and medicine by Polish migrants in Misiones, Argentina. Ecology of food and nutrition, 54, 255–279.
  • Lambert, J.D., et al., 2002. Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse. Toxicon, 40, 1701–1708.
  • Lambert, J.D., et al., 2010. Hepatotoxicity of high oral dose (–)-epigallocatechin-3-gallate in mice. Food and chemical toxicology, 48, 409–416.
  • Larrey, D., 1997. Hepatotoxicity of herbal remedies. Journal of hepatology, 26 Suppl 1, 47–51.
  • Lee, W.J., et al., 2015. Systematic review on herb-induced liver injury in Korea. Food and chemical toxicology, 84, 47–54.
  • Lefebvre, T., et al., 2004. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. Journal of pharmacy & pharmaceutical sciences, 7, 265–273.
  • Lekehal, M., et al., 1996. Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology, 24, 212–218.
  • Levitsky, J., et al., 2005. Fulminant liver failure associated with the use of black cohosh. Digestive diseases and sciences, 50, 538–539.
  • Li, S., et al., 2016. pigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3. Drug design, development and therapy, 10, 631.
  • Lin, B.R., et al., 2009. Green tea extract supplement reduces d-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling. Journal of biomedical science, 16, 35.
  • Liu, Y., et al., 2011. Effects of dietary phenolics and botanical extracts on hepatotoxicity-related endpoints in human and rat hepatoma cells and statistical models for prediction of hepatotoxicity. Food and chemical toxicology, 49, 1820–1827.
  • Loeper, J., et al., 1994. Hepatotoxicity of germander in mice. Gastroenterology, 106, 464–472.
  • Lohdefink, J. and Kating, H., 1974. Harmane alkaloids of Passiflora species. Planta medica, 25, 101–104.
  • Lozada-Lechuga, J., et al., 2010. Isolation of jacaranone, a sedative constituent extracted from the flowers of the Mexican tree Ternstroemia pringlei. Journal of ethnopharmacology, 127, 551–554.
  • Luca, V.S., et al., 2016. Catechins profile, caffeine content and antioxidant activity of Camellia sinensis teas commercialized in Romania. Revista medico-chirurgicala a societatii de medici si naturalisti din iasiiasi, 120, 457–463.
  • Lude, S., et al., 2007. Hepatic effects of Cimicifuga racemosa extract in vivo and in vitro. Cellular and molecular life sciences, 64, 2848–2857.
  • Lynch, C.R., Folkers, M.E., and Hutson, W.R., 2006. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver transplantation, 12, 989–992.
  • Macgregor, F.B., et al., 1989. Hepatotoxicity of herbal remedies. BMJ, 299, 1156–1157.
  • Madsen, C., Wurtzen, G., and Carstensen, J., 1986. Short-term toxicity study in rats dosed with menthone. Toxicology letters, 32, 147–152.
  • Mahmoud, M.F., et al., 2014. Hepatoprotective effect of limonin, a natural limonoid from the seed of Citrus aurantium var. bigaradia, on d-galactosamine-induced liver injury in rats. Naunyn-Schmiedeberg's archives of pharmacology, 387, 251–261.
  • Masadeh, M.M., et al., 2014. Anti-Helicobacter pylori activity of some Jordanian medicinal plants. Pharmaceutical biology, 52, 566–569.
  • Matsuda, H., et al., 2002. Hepatoprotective principles from the flowers of Tilia argentea (linden): structure requirements of tiliroside and mechanisms of action. Bioorganic & medicinal chemistry, 10, 707–712.
  • Mazaro-Costa, R., et al., 2010. Medicinal plants as alternative treatments for female sexual dysfunction: utopian vision or possible treatment in climacteric women? The journal of sexual medicine, 7, 3695–3714.
  • Mazzanti, G., et al., 2009a. Chelidonium majus is not hepatotoxic in Wistar rats, in a 4 weeks feeding experiment. Journal of ethnopharmacology, 126, 518–524.
  • Mazzanti, G., et al., 2009b. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. European journal of clinical pharmacology, 65, 331–341.
  • Mercader, J., et al., 2011. Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium. Journal of physiology and biochemistry, 67, 443–452.
  • México, U.N.a.D., 2009a. Biblioteca Digital de la Medicina Tradicional Mexicana [online]. Available from: http://www.medicinatradicionalmexicana.unam.mx/monografia.php?l=3&t=Hierbabuena&id =7675 [Accessed 12 May 2017].
  • México, U.N.a.D., 2009b. Biblioteca Digital de la Medicina Tradicional Mexicana [online]. Available from: http://www.medicinatradicionalmexicana.unam.mx/monografia.php?l=3&t=Naranja_agria&id=8005 [Accessed 15 May 2017].
  • México, U.N.a.D., 2009c. Biblioteca Digital de la Medicina Tradicional Mexicana [online]. Available from: http://www.medicinatradicionalmexicana.unam.mx/monografia.php?l=3&t=Gobernadora&id =7544 [Accessed 7 November 2016].
  • Miroddi, M., et al., 2013. Passiflora incarnata L.: ethnopharmacology, clinical application, safety and evaluation of clinical trials. Journal of ethnopharmacology, 150, 791–804.
  • Miyasaka, L.S., Atallah, A.N., and Soares, B., 2006. Valerian for anxiety disorders. Cochrane database of systematic reviews, (4), CD004515. doi: 10.1002/14651858.CD004515.pub2
  • Mizuno, S., et al., 1992. A multi-institute case-control study on the risk factors of developing pancreatic cancer. Japanese journal of clinical oncology, 22, 286–291.
  • Montanher, A.B., et al., 2007. Evidence of anti-inflammatory effects of Passiflora edulis in an inflammation model. Journal of ethnopharmacology, 109, 281–288.
  • Murakami, A., 2014. Dose-dependent functionality and toxicity of green tea polyphenols in experimental rodents. Archives of biochemistry and biophysics, 557, 3–10.
  • Navarro, V.J., 2009. Herbal and dietary supplement hepatotoxicity. Seminars in liver disease, 29, 373–382.
  • Navarro, V.J., et al., 2014. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology, 60, 1399–1408.
  • Newall, C., Anderson, L., and Phillipson, J.D., 1996. Herbal medicines. A guide for health care professionals. London: The Pharmaceutical Press.
  • Ni, Y., et al., 2004. Isolation and characterization of structural components of Aloe vera L. leaf pulp. International immunopharmacology, 4, 1745–1755.
  • Ortiz, O.M., et al., 2008. Valeriana en el tratamiento a largo plazo del insomnio. Revista colombiana de psiquiatría, 37, 614–626.
  • Pardini, R.S., Heidker, J.C., and Fletcher, D.C., 1970. Inhibition of mitochondrial electron transport by nor-dihydroguaiaretic acid (NDGA). Biochemical pharmacology, 19, 2695–2699.
  • Paz, N.E., 2008. Historia de los fitofármacos en la medicina. México, D.F.: Siegfried Rhein.
  • Pette, D., 1975. Some aspects of supramolecular organization of glycogenolytic and glycolytic enzymes in muscle. Acta histochemica. Supplementband, 14, 47–68.
  • Pinheiro, M.L., et al., 2014. Valeriana officinalis L. for conscious sedation of patients submitted to impacted lower third molar surgery: a randomized, double-blind, placebo-controlled split-mouth study. Journal of pharmacy and bioallied sciences, 6, 109–114.
  • Pittler, M.H. and Ernst, E., 2000. Efficacy of Kava extract for treating anxiety: systematic review and meta-analysis. Journal of clinical psychopharmacology, 20, 84–89.
  • Prakash, A.S., et al., 1999. Pyrrolizidine alkaloids in human diet. Mutation research, 443, 53–67.
  • Prasad, R., et al., 2010. Valeriana jatamansi partially reverses liver cirrhosis and tissue hyperproliferative response in rat. Methods and findings in experimental and clinical pharmacology, 32, 713–719.
  • Quintero Díaz, M., et al., 2009. Aloe gel viscoso® en el tratamiento de pacientes con úlcera duodenal y Helicobacter pylori positivo. Revista Cubana de plantas medicinales, 1414 (4). Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1028-47962009000400002&lng=es&nrm=iso [Accessed 13 Jun 2017].
  • Rabe, C., et al., 2005. Acute hepatitis induced by an Aloe vera preparation: a case report. World journal of gastroenterology, 11, 303–304.
  • Rafieian-Kopaei, M. and Movahedi, M., 2017. Breast cancer chemopreventive and chemotherapeutic effects of Camellia sinensis (green tea): an updated review. Electronic physician, 9, 3838–3844.
  • Rangel-Huerta, O.D., et al., 2015. Normal or high polyphenol concentration in orange juice affects antioxidant activity, blood pressure, and body weight in obese or overweight adults. The journal of nutrition, 145, 1808–1816.
  • Restani, P., et al., 2016. Adverse effects of plant food supplements self-reported by consumers in the PlantLIBRA survey involving six European countries. PLoS One, 11, e0150089.
  • Rodriguez-Fragoso, L., et al., 2008. Risks and benefits of commonly used herbal medicines in Mexico. Toxicology and applied pharmacology, 227, 125–135.
  • Rojas Rojas, T., et al., 2016. Herbal medicine practices of patients with liver cancer in Peru. Integrative cancer therapies, 1534735416681642. doi: 10.1177/1534735416681642
  • Rossato, L.G., et al., 2011. Synephrine: from trace concentrations to massive consumption in weight-loss. Food and chemical toxicology, 49, 8–16.
  • Roulet, M., et al., 1988. Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea. The journal of pediatrics, 112, 433–436.
  • Roy, A. and Saraf, S., 2006. Limonoids: overview of significant bioactive triterpenes distributed in plants kingdom. Biological and pharmaceutical bulletin, 29, 191–201.
  • Russmann, S., Lauterburg, B.H., and Helbling, A., 2001. Kava hepatotoxicity. Annals of internal medicine, 135, 68–69.
  • Sahu, S.C. and Gray, G.C., 1996. Pro-oxidant activity of flavonoids: effects on glutathione and glutathione S-transferase in isolated rat liver nuclei. Cancer letters, 104, 193–196.
  • Sahu, S.C., Ruggles, D.I., and O'donnell, M.W., 2006. Prooxidant activity and toxicity of nordihydroguaiaretic acid in clone-9 rat hepatocyte cultures. Food and chemical toxicology, 44, 1751–1757.
  • Sajilata, M.G., Bajaj, P.R., and Singhal, R.S., 2008. Tea polyphenols as nutraceuticals. Comprehensive reviews in food science and food safety, 7, 229–254.
  • Salgado, N., et al., 2015. Radical scavenging, antioxidant, and cytotoxic activities of the methanolic extracts from different organs of Ternstroemia pringlei. Pakistan journal of pharmaceutical sciences, 28, 2279–2284.
  • Salminen, W.F., et al., 2012. Green tea extract can potentiate acetaminophen-induced hepatotoxicity in mice. Food and chemical toxicology, 50, 1439–1446.
  • Saper, R.B., et al., 2008. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA, 300, 915–923.
  • Sarma, D.N., et al., 2008. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug safety, 31, 469–484.
  • Sarris, J., Laporte, E., and Schweitzer, I., 2011. Kava: a comprehensive review of efficacy, safety, and psychopharmacology. The Australian and New Zealand journal of psychiatry, 45, 27–35.
  • Scarpa, G.F., 2004. Medicinal plants used by the Criollos of Northwestern Argentine Chaco. Journal of ethnopharmacology, 91, 115–135.
  • Schiano, T.D., 2003. Hepatotoxicity and complementary and alternative medicines. Clinics in liver disease, 7, 453–473.
  • Schjøtt, J., 2011. Adverse effects of drugs and toxins on the liver. In: Y. Mizuguchi, ed. Liver biopsy in modern medicine. Norway: InTech. doi: 10.5772/23720. Available from: https://www.intechopen.com/books/liver-biopsy-in-modern-medicine/adverse-effects-of-drugs-and-toxins-on-the-liver
  • Schmutz, J.L., Barbaud, A., and Trechot, P., 2008. Adverse effects of Cimicifuga. Annales de dermatologie et de venereologie, 135, 170.
  • Seeff, L., Stickel, F., and Navarro, V.J., 2013. Chapter 35 – hepatotoxicity of herbals and dietary supplements A2 – Kaplowitz, Neil. In: L.D. Deleve, ed. Drug-induced liver disease (third edition). Boston: Academic Press, 631–657.
  • Seeff, L.B., et al., 2015. Herbal products and the liver: a review of adverse effects and mechanisms. Gastroenterology, 148, 517–532.e3.
  • Seigler, D.S., et al., 2002. Cyanogenic allosides and glucosides from Passiflora edulis and Carica papaya. Phytochemistry, 60, 873–882.
  • Sghaier, M.B., et al., 2016. Leaf extracts from Teucrium ramosissimum protect against DNA damage in human lymphoblast cell K562 and enhance antioxidant, antigenotoxic and antiproliferative activity. Environmental toxicology and pharmacology, 44, 44–52.
  • Shanmugam, S., et al., 2016. Effects of luteolin and quercetin 3-beta-d-glucoside identified from Passiflora subpeltata leaves against acetaminophen induced hepatotoxicity in rats. Biomedicine & pharmacotherapy, 83, 1278–1285.
  • Shawahna, R. and Jaradat, N.A., 2017. Ethnopharmacological survey of medicinal plants used by patients with psoriasis in the West Bank of Palestine. BMC complementary and alternative medicine, 17, 4.
  • Sheikh, N.M., Philen, R.M., and Love, L.A., 1997. Chaparral-associated hepatotoxicity. Archives of internal medicine, 157, 913–919.
  • Singh, B.N., Shankar, S., and Srivastava, R.K., 2011. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemical pharmacology, 82, 1807–1821.
  • Singh, Y.N., 2005. Potential for interaction of kava and St. John’s wort with drugs. Journal of ethnopharmacology, 100, 108–113.
  • Soares Mdo, C., 2004. Would Sacaca, Croton cajucara Benth (Euphorbiaceae) be an hepatotoxic plant like Germander, Teucrium chamaedrys L. (Labiatae)? Revista da sociedade brasileira de medicina tropical, 37 Suppl 2, 96–97.
  • Song, D.K., et al., 1996. Antidepressant-like effects of p-synephrine in mouse models of immobility tests. Neuroscience letters, 214, 107–110.
  • Sorrentino, L., Capasso, A., and Schmidt, M., 2006. Safety of ethanolic kava extract: results of a study of chronic toxicity in rats. Phytomedicine, 13, 542–549.
  • Stedman, C., 2002. Herbal hepatotoxicity. Seminars in liver disease, 22, 195–206.
  • Stickel, F. and Shouval, D., 2015. Hepatotoxicity of herbal and dietary supplements: an update. Archives of toxicology, 89, 851–865.
  • Stohs, S.J., Preuss, H.G., and Shara, M., 2012. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. International journal of medical sciences, 9, 527–538.
  • Storsrud, S., Ponten, I., and Simren, M., 2015. A pilot study of the effect of Aloe barbadensis Mill. extract (AVH200(R)) in patients with irritable bowel syndrome: a randomized, double-blind, placebo-controlled study. Journal of gastrointestinal and liver diseases, 24, 275–280.
  • Stournaras, E. and Tziomalos, K., 2015. Herbal medicine-related hepatotoxicity. World journal of hepatology, 7, 2189–2193.
  • Strader, D.B. and Seeff, L.B., 2012. Hepatotoxicity of herbal preparations. In: T.D. Boyer, M.P. Manns, A.J. Sanyal, and D. Zakim, editors. Zakim & Boyer’s hepatology. Saint Louis: W.B. Saunders.
  • Strader, D.B., Navarro, V.J., and Seeff, L.B., 2012. Chapter 26 – hepatotoxicity of herbal preparations A2 – Boyer, Thomas D. In: M.P. Manns and A.J. Sanyal, eds. Zakim and Boyer’s hepatology (sixth edition). Saint Louis: W.B. Saunders, 462–475.
  • Strader, D.B., et al., 2002. Use of complementary and alternative medicine in patients with liver disease. The American journal of gastroenterology, 97, 2391–2397.
  • Tariq, M., et al., 1989. Anti-inflammatory activity of Teucrium polium. International journal of tissue reactions, 11, 185–188.
  • Teschke, R., 2010. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver international, 30, 1270–1279.
  • Teschke, R. and Eickhoff, A., 2015. Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Frontiers in pharmacology, 6, 72.
  • Teschke, R., et al., 2012a. Greater Celandine hepatotoxicity: a clinical review. Annals of hepatology, 11, 838–848.
  • Teschke, R., et al., 2012b. Suspected Greater Celandine hepatotoxicity: liver-specific causality evaluation of published case reports from Europe. European journal of gastroenterology & hepatology, 24, 270–280.
  • Teschke, R., et al., 2013. Clinical and causality assessment in herbal hepatotoxicity. Expert opinion on drug safety, 12, 339–366.
  • Teschke, R., Gaus, W., and Loew, D., 2003. Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine, 10, 440–446.
  • Teschke, R., Qiu, S.X., and Lebot, V., 2011. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Digestive and liver disease, 43, 676–681.
  • Teschke, R., Schwarzenboeck, A., and Akinci, A., 2008. Kava hepatotoxicity: a European view. The New Zealand medical journal, 121, 90–98.
  • Thummel, K.E. and Wilkinson, G.R., 1998. In vitro and in vivo drug interactions involving human CYP3A. Annual review of pharmacology and toxicology, 38, 389–430.
  • Toker, G., et al., 2001. Comparative evaluation of the flavonoid content in officinal Tiliae flos and Turkish lime species for quality assessment. Journal of pharmaceutical and biomedical analysis, 26, 111–121.
  • Tran, A., Pratt, M., and Dekoven, J., 2010. Acute allergic contact dermatitis of the lips from peppermint oil in a lip balm. Dermatitis, 21, 111–115.
  • Tsubono, Y., et al., 2001. Green tea and the risk of gastric cancer in Japan. The New England journal of medicine, 344, 632–636.
  • U.S., F.D.A., 2016. What is the difference between a dietary supplement and conventional food? [online]. Available from: http://www.fda.gov/AboutFDA/Transparency/Basics/ucm194357.htm [Accessed 11 July 2016].
  • Valdivia-Correa, B., et al., 2016. Herbal medicine in Mexico: a cause of hepatotoxicity. A critical review. International journal of molecular sciences, 17, 235.
  • Valiente-Banuet, A., et al., 1998. The chaparral vegetation in Mexico undernonmediterranean climate: the convergence and Madrean-Tethyan hypothesesreconsidered. American journal of botany, 85, 1398–1408.
  • Vasic, S.M., et al., 2012. Biological activities of extracts from cultivated Granadilla Passiflora alata. EXCLI journal, 11, 208–218.
  • Vassiliadis, T., et al., 2009. Valeriana hepatotoxicity. Sleep medicine, 10, 935.
  • Vera-Montenegro, Y., et al., 2008. In vitro fasciolicide activity of some plant extracts against newly excysted flukes. Annals of the New York academy of sciences, 1149, 180–182.
  • Verma, R.S., et al., 2011. Chemical diversity in the essential oil of Indian valerian (Valeriana jatamansi Jones). Chemistry & biodiversity, 8, 1921–1929.
  • Vigano, M., Lampertico, P., and Colombo, M., 2008. Acute hepatitis following assumption of a herbal remedy. European journal of gastroenterology & hepatology, 20, 364–365.
  • Villet, S., et al., 2016. Open-label observational study of the homeopathic medicine Passiflora Compose for anxiety and sleep disorders. Homeopathy, 105, 84–91.
  • Vo, L.T., Chan, D., and King, R.G., 2003. Investigation of the effects of peppermint oil and valerian on rat liver and cultured human liver cells. Clinical and experimental pharmacology and physiology, 30, 799–804.
  • Wang, X., Kanel, G.C., and Deleve, L.D., 2000. Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat. Hepatology, 31, 428–434.
  • Whiting, P.W., Clouston, A., and Kerlin, P., 2002. Black cohosh and other herbal remedies associated with acute hepatitis. The medical journal of Australia, 177, 440–443.
  • Yang, H.N., et al., 2010. Aloe-induced toxic hepatitis. Journal of Korean medical science, 25, 492–495.
  • Zhang, Y.J., et al., 2016. The effects of Syzygium samarangense, Passiflora edulis and Solanum muricatum on alcohol-induced liver injury. International journal of molecular sciences, 17 (10). pii: E1616.
  • Zhong, Z., et al., 2003. Polyphenols from Camellia sinensis attenuate experimental cholestasis-induced liver fibrosis in rats. American journal of physiology – gastrointestinal and liver physiology, 285, G1004–G1013.
  • Zong, L., et al., 2011. Preliminary experimental research on the mechanism of liver bile secretion stimulated by peppermint oil. Journal of digestive diseases, 12, 295–301.
  • Zuniga Rojas, J., 1981. Oil seeds from the American tropics. Archivos latinoamericanos de nutrición, 31, 350–370.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.